Paulo Fernandes is a distinguished clinical research executive with extensive experience in international clinical trials across various phases and therapeutic areas. With a solid foundation in the CRO industry, he has successfully held roles in project management, start-up, operations management, and business development. Paulo has worked at renowned CROs such as PPD, Covance, and IQVIA. Recently, he structured a healthcare sector start-up for a group of investors, showcasing his entrepreneurial spirit and commitment to high-impact public health initiatives. Additionally, he has 10 years of experience at the Brazilian Association of Clinical Research Organizations, including 4 years as the President of the Board of Directors. Paulo holds a specialization in Clinical Pharmacology from USCS, a degree in Pharmacy and Biochemistry from FCF-USP, and training in Business and Project Management from FIA, along with an Executive MBA from INSPER.
Paulo Fernandes, C2O Fundador & Principal
Subscribe to Our Newsletter
Get the latest on clinical trials in Latin America — regulatory updates, market access strategies & industry trends. Delivered straight to your inbox.
Email has been submitted.
Recent Episodes
- Allison Komiyama, CEO and Founder at Bluestocking Health, LLC
- Daniel Zequeto, Founder & CEO at ODC Life Sciences
- Satabhisa Mukhopadhyay, Founder & Chief Scientist at 4D Path Inc
- Deborah Morley, Director CV Strategy and Delivery at RQM+
- Leonara vidal, Global Clinical Affairs Lead at Gentell
- Gerardo Noriega, Presiden & CEO at PercAssist, Inc
- Matt DeNardo, Chief Product Officer at Axoft
- Daniel Chen, Founder and CEO at Synthetic Design Lab
- Shareef Mahdavi, Founder at PX Movement
- See all →